Form D · Biotechnology
Phoreus Biotechnology, Inc.
Olathe, KS · CIK 0001748964
Offering snapshot reported Mar 13, 2026 · SEC filing
- Reported sold
- $421K Indefinite offering
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 5, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 13, 2026 | Initial | $420,693 | No comparison | 3 | SEC filing |
| Mar 13, 2026 | Amendment | $4,434,630 | $2,505,238vs May 11, 2022 | 49 | SEC filing |
| May 11, 2022 | Amendment | $1,929,392 | No comparison | 23 | SEC filing |
| May 26, 2020 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Dec 30, 2019 | Amendment | $550,000 | $500,000vs Aug 2, 2018 | 7 | SEC filing |
| Jul 19, 2019 | Amendment | $300,000 | $250,000vs Aug 2, 2018 | 4 | SEC filing |
| Aug 2, 2018 | Initial | $50,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-576537
Source: Form D, filed Mar 13, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Bill Ashley | Director, Promoter |
| Christopher Brandt | Director |
| Michael Coe | Director, Executive |
| Bradley Holliday | Director |
| Scott Nagley | Director |
| Rajeet Pannu | Director, Promoter |
| Lynn Rundle | Director |
| David Schaefer | Director, Executive, Promoter |
| Steve Schram | Director, Promoter |
| Douglas` Shane | Director, Promoter |
| Douglas Shane | Director, Promoter |
| Nathan Singh | Director |
| Xiomara Sinisterra Hunter | Director |
| Matthew Tomich | Director, Promoter |
| Randall Tosh | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
22201 W. Innovation Drive
Olathe, KS, 66061
Olathe, KS, 66061